GlassScriptPhysician profile
Sarah Greer
NPI 1669072708
$889.98
in general payments reported to CMS, 2019-2025
18 companies · $129 in 2025
The $129 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $150 · 2022: $188 · 2023: $312 · 2024: $111 · 2025: $129.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $552.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $551.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $238.76 | 2021-2024 | Yupelri |
| Avanir Pharmaceuticals, INC. | $96.33 | 2021-2022 | |
| Amgen INC. | $78.24 | 2022-2023 | Otezla, Repatha |
| Lilly USA, LLC | $62.07 | 2022-2025 | Jardiance, Mounjaro |
| Astrazeneca Pharmaceuticals LP | $60.51 | 2021-2024 | Airsupra, Farxiga |
| Viatris Specialty LLC | $50.86 | 2025 | Yupelri |
| Abbvie INC. | $44.13 | 2021-2023 | |
| Biofrontera INC. | $37.30 | 2024 | Ameluz, Xepi, Bf-Rhodoled |
| Exact Sciences Corporation | $36.80 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Pfizer INC. | $33.42 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $29.34 | 2025 | |
| Dexcom, INC. | $24.52 | 2023 | Dexcom G6 Transmitter |
| Radius Health, INC. | $20.32 | 2023 | Tymlos |
| Kowa Pharmaceuticals America, INC. | $19.13 | 2023 | Seglentis, Livalo |
| Antares Pharma, INC. | $17.47 | 2023 | Tlando, Nocdurna, Xyosted |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $17.08 | 2023 | Quviviq |
| Glaxosmithkline, LLC. | $12.61 | 2021 | |
| Urovant Sciences INC | $11.09 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Greer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.